Corneal epithelial stem cells
Showing 1 - 25 of >10,000
Corneal Ulcer, Corneal Disease, Corneal Dystrophy Trial in Minsk (mesenchymal stem cells, limbal stem cells, standard treatment)
Completed
- Corneal Ulcer
- +2 more
- mesenchymal stem cells
- +2 more
-
Minsk, BelarusInstitute of Biophysics and Cell Engineering of National Academy
Jul 28, 2020
Stem Cell Transplantation Trial in Cairo (conjunctival limbal autologous transplant)
Recruiting
- Stem Cell Transplantation
- conjunctival limbal autologous transplant
-
Cairo, EgyptKasr Alainy
Aug 9, 2022
Ophthalmological Disorder, Corneal Dystrophy, Treatment Trial in Alicante (Implantation, Lipoaspiration)
Recruiting
- Ophthalmological Disorder
- +4 more
- Implantation
- Lipoaspiration
-
Alicante, SpainJorge L. Alio
Oct 18, 2022
Limbal Stem Cell Deficiency Trial in Boston (Biopsy to collect limbal epithelial stem cells that will be cultivated into a
Active, not recruiting
- Limbal Stem Cell Deficiency
- Biopsy to collect limbal epithelial stem cells that will be cultivated into a graft
- +2 more
-
Boston, MassachusettsMassachusetts Eye and Ear Infirmary
Mar 21, 2022
Corneal Ulcer Trial in Chicago (Mesenchymal Stromal Cells, Control Solution)
Not yet recruiting
- Corneal Ulcer
- Mesenchymal Stromal Cells
- Control Solution
-
Chicago, IllinoisDepartment of Ophthalmology and Visual Sciences
Jan 21, 2023
Idiopathic Parkinson's Disease Trial in Shanghai (hAESCs)
Not yet recruiting
- Idiopathic Parkinson's Disease
- hAESCs
-
Shanghai, Shanghai, ChinaShanghai East Hospital
Jan 28, 2023
Limbal Stem Cells Deficiency Trial in Milan (Biopsy from donor eye, Implant of Holoclar, Ophtalmologic examination)
Completed
- Limbal Stem Cells Deficiency
- Biopsy from donor eye
- +7 more
-
Milan, ItalyHospital San Raffaele
Mar 31, 2022
After ACLSCT for Restoration of Corneal Epithelium in LSCD Due
Active, not recruiting
- Limbal Stem Cell Deficiency Due to Ocular Burn
- Ophthalmologic examinations
- +2 more
-
Milan, ItalyHospital San Raffaele
Aug 8, 2022
Corneal Scars and Opacities Trial (Ex-vivo cultivated Allogeneic limbal stromal stem cells)
Not yet recruiting
- Corneal Scars and Opacities
- Ex-vivo cultivated Allogeneic limbal stromal stem cells
- (no location specified)
Jun 12, 2021
Ovarian Cancer Trial in Chongqing (Autologous blood transfusion with haematopoietic stem cells)
Recruiting
- Ovarian Cancer
- Autologous blood transfusion with haematopoietic stem cells
-
Chongqing, Chongqing, ChinaChongqing University Cancer Hospital
May 29, 2022
Myocardial Infarction, Heart Diseases Trial in Jakarta, Depok (Heart patch seeded with autologous cardiomyocytes and amnion
Recruiting
- Myocardial Infarction
- Heart Diseases
- Heart patch seeded with autologous cardiomyocytes and amnion epithelial stem cells
-
Jakarta, DKI Jakarta, Indonesia
- +2 more
Feb 14, 2022
Production of iPSC Derived RPE Cells for Transplantation in AMD
Completed
- Age Related Macular Degeneration (AMD)
- (no location specified)
Apr 4, 2022
Cultivated Limbal Epithelial Transplantation for Limbal Stem
Not yet recruiting
- Limbal Stem-cell Deficiency
-
Valladolid, SpainIOBA
Feb 4, 2022
Limbal Stem Cell Deficiency Trial in Germany, United States (LSC2)
Active, not recruiting
- Limbal Stem Cell Deficiency
- LSC2
-
Boston, Massachusetts
- +4 more
Oct 6, 2022
Ovarian Cancer Trial in Oklahoma City (Unesbulin)
Active, not recruiting
- Ovarian Cancer
-
Oklahoma City, OklahomaUniversity of Oklahoma Health Sciences Center
Feb 21, 2022
Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal
Active, not recruiting
- Platinum-Resistant Fallopian Tube Carcinoma
- +11 more
- Aldesleukin
- +3 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jul 13, 2022
Parkinson's Disease Trial in Shanghai (hAESCs treatment, (saline))
Not yet recruiting
- Parkinson's Disease
- hAESCs treatment
- placebo (saline)
-
Shanghai, Shanghai, ChinaJingwen Wu
Jun 23, 2022
Total Bilateral Limbal Cell Deficiency Trial in Lyon (FEMJA transplatation)
Recruiting
- Total Bilateral Limbal Cell Deficiency
- FEMJA transplatation
-
Lyon, FranceOphthalmology department, Edouard Herriot hospital, Hospices Civ
Jan 26, 2022
Mesenchymal Stromal Cells, Cornea, Safety Trial in Chicago (Allogeneic MSC)
Recruiting
- Mesenchymal Stromal Cells
- +3 more
- Allogeneic MSC
-
Chicago, IllinoisUniversity of Illinois, Department of Ophthalmology and Visual S
Apr 19, 2022
Recurrent Ovarian Carcinoma, Platinum-resistant Ovarian Cancer Trial in United States (ChemoID Assay, Standard Chemotherapy)
Recruiting
- Recurrent Ovarian Carcinoma
- Platinum-resistant Ovarian Cancer
- ChemoID Assay
- Standard Chemotherapy
-
Phoenix, Arizona
- +9 more
Oct 16, 2021
Corneal Transplantation Trial in Cologne (Corneal Crosslinking)
Not yet recruiting
- Corneal Transplantation
- Corneal Crosslinking
-
Cologne, NRW, GermanyUniversity Hospital of Cologne, Centre for Ophthalmology
May 21, 2023
Stargardt's Macular Dystrophy Trial in Edinburgh, London, Newcastle upon Tyne (MA09-hRPE)
Completed
- Stargardt's Macular Dystrophy
- MA09-hRPE
-
Edinburgh, United Kingdom
- +2 more
Jul 4, 2021
Limbal Stem-cell Deficiency, Congenital Aniridia Trial in Minneapolis (transplantation of a Descemet's Membrane corneal onlay,
Not yet recruiting
- Limbal Stem-cell Deficiency
- Congenital Aniridia
- transplantation of a Descemet's Membrane corneal onlay, partial LSCD
- transplantation of a Descemet's Membrane corneal onlay, total/near-total LSCD
-
Minneapolis, MinnesotaUniversity of Minnesota
Jun 15, 2023
Limbus Corneae, Limbus Corneae Insufficiency Syndrome Trial in Seoul (LSCD101 (Cultured Autologous Limbal Epithelial Cell Sheet)
Completed
- Limbus Corneae
- Limbus Corneae Insufficiency Syndrome
- LSCD101 (Cultured Autologous Limbal Epithelial Cell Sheet) transplantation
-
Seoul, Korea, Republic ofCliPS
Feb 24, 2021
Cell- and Tissue-Based Therapy Trial in Jakarta Pusat (Amnion only, Amnion - endometrium cells, Amnion - amnion epithelial
Unknown status
- Cell- and Tissue-Based Therapy
- Amnion only
- +3 more
-
Jakarta Pusat, DKI Jakarta, IndonesiaRSUPN Cipto Mangunkusumo
Dec 15, 2020